[Role of catecholamine depots and alpha-adrenoreceptors in the radiation-protective effect of hydroxyphenylethanolamines].
D000818:Animals; D002395:Catecholamines / Q000627:therapeutic use*; D003042:Cocaine / Q000627:therapeutic use; D003983:Dibenzylchlorethamine / Q000627:therapeutic use; D008297:Male; D051379:Mice; D010646:Phentolamine / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000502:physiology*
D002395:Catecholamines; D011837:Radiation-Protective Agents; D011955:Receptors, Drug; D010656:Phenylephrine; D003983:Dibenzylchlorethamine; D003042:Cocaine; D010646:Phentolamine
Issedovanie uchastiia katekholaminovykh depo i alfa-adrenoretseptorov v radiozashchitnom éffekte oksifenilétanolaminov.